Table 4 Comparison of clinical characteristics according to whether SB development in patients
Characteristics | Without SB (n = 56) | With SB (n = 26) | P value |
|---|---|---|---|
Age (years) | 58 (52–63) | 54 (51–64) | 0.788 |
Men, n (%) | 15 (27) | 9 (35) | 0.468 |
Smoker, n (%) | 10 (18) | 5 (19) | 0.881 |
Drinker, n (%) | 3 (5) | 0 (0) | 0.229 |
Body mass index, kg/m2 | 23.95 ± 3.34 | 23.65 ± 2.55 | 0.686 |
Hypertension, n (%) | 4 (7) | 6 (23) | 0.040 |
Diabetes, n (%) | 2 (4) | 2 (8) | 0.420 |
ALT (U/L) | 24.5 (17–37.5) | 17.5 (13–26.95) | 0.122 |
AST (U/L) | 24.5 (18.25–30.75) | 21 (17.75–27.75) | 0.247 |
Total bilirubin (μmol/L) | 16.85 (12.13–23.38) | 13.8 (11.35–23.68) | 0.458 |
Partial pressure of oxygen (mmHg) | 85.35 (74.45–94.43) | 88.2 (79.55–94.5) | 0.397 |
Pro-BNP (ng/ml) | 1452.5 (753.9–2435.75) | 1181 (572.3–2086.25) | 0.140 |
LV ejection fraction (%) | 58.52 ± 8.40 | 59.71 ± 5.43 | 0.510 |
Pulmonary systolic blood pressure (mmHg) | 36.57 ± 9.17 | 42.23 ± 11.08 | 0.017 |
LV end-diastolic dimension (mm) | 51 (46.25–54) | 51 (46–55.25) | 0.747 |
RV diameter (mm) | 25.66 ± 67.06 | 17 ± 4.28 | 0.514 |
RV outflow tract diameter (mm) | 25.96 ± 4.65 | 25.77 ± 2.85 | 0.844 |
TR area (cm2) | 2.55 (1.5–4.5) | 6.2 (5.38–8.68) | 0.000 |
AF duration time (y) | 2 (0.2–5) | 0.5 (0.1–2) | 0.176 |
Preoperative heart rate | 84 (70–102) | 94 (75–111) | 0.250 |
Euroscore II (%) | 1.09 ± 0.38 | 1.09 ± 0.46 | 0.159 |